Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

Simple item page
dc.contributor.authorBédard A.
dc.contributor.authorBasagaña X.
dc.contributor.authorAnto J.M.
dc.contributor.authorGarcia-Aymerich J.
dc.contributor.authorDevillier P.
dc.contributor.authorArnavielhe S.
dc.contributor.authorBedbrook A.
dc.contributor.authorOnorato G.L.
dc.contributor.authorCzarlewski W.
dc.contributor.authorMurray R.
dc.contributor.authorAlmeida R.
dc.contributor.authorFonseca J.
dc.contributor.authorCosta E.
dc.contributor.authorMalva J.
dc.contributor.authorMorais-Almeida M.
dc.contributor.authorPereira A.M.
dc.contributor.authorTodo-Bom A.
dc.contributor.authorMenditto E.
dc.contributor.authorStellato C.
dc.contributor.authorVentura M.T.
dc.contributor.authorCruz A.A.
dc.contributor.authorStelmach R.
dc.contributor.authorda Silva J.
dc.contributor.authorLarenas-Linnemann D.
dc.contributor.authorFuentes-Pérez J.M.
dc.contributor.authorHuerta-Villalobos Y.R.
dc.contributor.authorEmuzyte R.
dc.contributor.authorKvedariene V.
dc.contributor.authorValiulis A.
dc.contributor.authorKuna P.
dc.contributor.authorSamolinski B.
dc.contributor.authorKlimek L.
dc.contributor.authorMösges R.
dc.contributor.authorPfaar O.
dc.contributor.authorShamai S.
dc.contributor.authorAnnesi-Maesano I.
dc.contributor.authorBosse I.
dc.contributor.authorDemoly P.
dc.contributor.authorFontaine J.-F.
dc.contributor.authorCardona V.
dc.contributor.authorMullol J.
dc.contributor.authorValero A.
dc.contributor.authorRoller-Wirnsberger R.E.
dc.contributor.authorTomazic P.V.
dc.contributor.authorChavannes N.H.
dc.contributor.authorFokkens W.J.
dc.contributor.authorReitsma S.
dc.contributor.authorBewick M.
dc.contributor.authorRyan D.
dc.contributor.authorSheikh A.
dc.contributor.authorHaahtela T.
dc.contributor.authorToppila-Salmi S.
dc.contributor.authorValovirta E.
dc.contributor.authorMakris M.
dc.contributor.authorPapadopoulos N.G.
dc.contributor.authorProkopakis E.P.
dc.contributor.authorPsarros F.
dc.contributor.authorCingi C.
dc.contributor.authorGemicioğlu B.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorBosnic-Anticevich S.
dc.contributor.authorO'Hehir R.E.
dc.contributor.authorBachert C.
dc.contributor.authorHellings P.W.
dc.contributor.authorPugin B.
dc.contributor.authorBindslev-Jensen C.
dc.contributor.authorEller E.
dc.contributor.authorKull I.
dc.contributor.authorMelén E.
dc.contributor.authorWickman M.
dc.contributor.authorDe Vries G.
dc.contributor.authorvan Eerd M.
dc.contributor.authorAgache I.
dc.contributor.authorAnsotegui I.J.
dc.contributor.authorDykewicz M.S.
dc.contributor.authorCasale T.
dc.contributor.authorWallace D.
dc.contributor.authorWaserman S.
dc.contributor.authorLaune D.
dc.contributor.authorBousquet J.
dc.date.accessioned2024-07-22T08:08:27Z
dc.date.available2024-07-22T08:08:27Z
dc.date.issued2019
dc.description.abstractBackground: Mobile health can be used to generate innovative insights into optimizing treatment to improve allergic rhinitis (AR) control. Objectives: A cross-sectional real-world observational study was undertaken in 22 countries to complement a pilot study and provide novel information on medication use, disease control, and work productivity in the everyday life of patients with AR. Methods: A mobile phone app (Allergy Diary, which is freely available on Google Play and Apple stores) was used to collect the data of daily visual analogue scale (VAS) scores for (1) overall allergic symptoms; (2) nasal, ocular, and asthma symptoms; (3) work; and (4) medication use by using a treatment scroll list including all allergy medications (prescribed and over-the-counter) customized for 22 countries. The 4 most common intranasal medications containing intranasal corticosteroids and 8 oral H1-antihistamines were studied. Results: Nine thousand one hundred twenty-two users filled in 112,054 days of VASs in 2016 and 2017. Assessment of days was informative. Control of days with rhinitis differed between no (best control), single (good control for intranasal corticosteroid–treated days), or multiple (worst control) treatments. Users with the worst control increased the range of treatments being used. The same trend was found for asthma, eye symptoms, and work productivity. Differences between oral H1-antihistamines were found. Conclusions: This study confirms the usefulness of the Allergy Diary in accessing and assessing behavior in patients with AR. This observational study using a very simple assessment tool (VAS) on a mobile phone had the potential to answer questions previously thought infeasible. © 2019 American Academy of Allergy, Asthma & Immunology
dc.identifier.DOI-ID10.1016/j.jaci.2019.01.053
dc.identifier.issn00916749
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/14384
dc.language.isoEnglish
dc.publisherMosby Inc.
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectAdolescent
dc.subjectAdrenal Cortex Hormones
dc.subjectAdult
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectEfficiency
dc.subjectFemale
dc.subjectHistamine H1 Antagonists
dc.subjectHumans
dc.subjectInfant
dc.subjectInfant, Newborn
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectMobile Applications
dc.subjectRhinitis, Allergic
dc.subjectSymptom Assessment
dc.subjectVisual Analog Scale
dc.subjectYoung Adult
dc.subjectbilastine
dc.subjectcetirizine
dc.subjectcorticosteroid
dc.subjectdesloratadine
dc.subjectebastine
dc.subjectfexofenadine
dc.subjectlevocetirizine
dc.subjectloratadine
dc.subjectrupatadine
dc.subjectcorticosteroid
dc.subjecthistamine H1 receptor antagonist
dc.subjectadolescent
dc.subjectadult
dc.subjectaged
dc.subjectallergic rhinitis
dc.subjectArticle
dc.subjectasthma
dc.subjectchild
dc.subjectcross-sectional study
dc.subjectdemography
dc.subjectdisease control
dc.subjectfemale
dc.subjecthuman
dc.subjectinfant
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmobile application
dc.subjectmonotherapy
dc.subjectnewborn
dc.subjectobservational study
dc.subjectpilot study
dc.subjectpriority journal
dc.subjectvisual analog scale
dc.subjectallergic rhinitis
dc.subjectmiddle aged
dc.subjectpreschool child
dc.subjectproductivity
dc.subjectsymptom assessment
dc.subjectvery elderly
dc.subjectyoung adult
dc.titleMobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study
dc.typeArticle

Files

Collections

Scopus Koleksiyonu